Matches in Wikidata for { <http://www.wikidata.org/entity/Q79112163> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q79112163 description "clinical trial" @default.
- Q79112163 description "ensayu clínicu" @default.
- Q79112163 description "klinisch onderzoek" @default.
- Q79112163 description "клінічне випробування" @default.
- Q79112163 name "Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure" @default.
- Q79112163 name "Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure" @default.
- Q79112163 type Item @default.
- Q79112163 label "Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure" @default.
- Q79112163 label "Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure" @default.
- Q79112163 prefLabel "Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure" @default.
- Q79112163 prefLabel "Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure" @default.
- Q79112163 P1132 Q79112163-D6E7B3F0-4273-44BE-B989-3532A37FC271 @default.
- Q79112163 P1476 Q79112163-13A72243-FE9C-49FD-AB92-99E50B04B723 @default.
- Q79112163 P17 Q79112163-AD02973D-8BB7-4002-A9AF-7F2372B1B59C @default.
- Q79112163 P1813 Q79112163-761B19F6-8910-4D34-A281-CBB664B8F531 @default.
- Q79112163 P2899 Q79112163-B9957C35-2F8C-4C39-A0B6-D0D39DC94FBE @default.
- Q79112163 P3098 Q79112163-6039CA3F-80A2-4FD7-8534-9B522AE43994 @default.
- Q79112163 P31 Q79112163-DC1D2B9B-20E6-4614-9442-5958C18ACE3F @default.
- Q79112163 P580 Q79112163-24DCAB1D-4826-462D-8168-32E33F56726B @default.
- Q79112163 P582 Q79112163-93311362-63D9-4BAA-A33D-39C77B6FD4A2 @default.
- Q79112163 P6099 Q79112163-DF961D22-46F7-407F-B620-D24B89B3CA74 @default.
- Q79112163 P8363 Q79112163-3E50F4B2-9866-4274-BE2B-B9A6902AB6F5 @default.
- Q79112163 P859 Q79112163-BEF64F90-75A2-44A6-AA3A-B0217C8413A6 @default.
- Q79112163 P1132 "+74" @default.
- Q79112163 P1476 "A Multicentre, Comparative, Placebo-controlled, Double-blinded, Phase II Study of the Efficacy of Lenvatinib in Patients With Locally Advanced or Metastatic GIST After Failure of Imatinib and Sunitinib" @default.
- Q79112163 P17 Q142 @default.
- Q79112163 P1813 "LENVAGIST" @default.
- Q79112163 P2899 "+18" @default.
- Q79112163 P3098 "NCT04193553" @default.
- Q79112163 P31 Q30612 @default.
- Q79112163 P580 "2019-12-01T00:00:00Z" @default.
- Q79112163 P582 "2022-03-01T00:00:00Z" @default.
- Q79112163 P6099 Q42824440 @default.
- Q79112163 P8363 Q78089383 @default.
- Q79112163 P859 Q2944832 @default.